Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Epidemiological update: H3N2v cases in Ohio, US, 4 September 2014
In August 2014, the US Centers for Disease Control and Prevention (CDC) reported two laboratory-confirmed human infections with a A(H3N2) variant influenza virus of swine origin A(H3N2)v in Ohio, USA.
Very low public health threat related to outbreak of avian influenza A(H5N8) in turkeys in Germany
The risk of transmission of avian influenza A(H5N8) to the general public in the EU/EEA countries is extremely low.
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt, 9 April 2015
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt
Recent upsurge of A(H7N9) cases in China, updated rapid risk assessment
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China. At present, the most immediate threat to EU citizens is to those living or visiting influenza A(H7N9)-affected areas in China concludes the updated rapid risk assessment.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
Options IX for the Control of Influenza ConferenceArchived
Options IX was the largest international conference exclusively devoted to influenza prevention, control and treatment.
True swine influenza in humans: recent different findings in the United States and Europe (Germany)Archived
This report describes the investigation of two cases of febrile respiratory illness caused by swine influenza A (H3N2) viruses identified on the 19th and the 26th August 2011 in two different states in the US (Indiana and Pennsylvania).